ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1014

Test-Retest Reliability Of Five Global Measures Addressing At Work Limitations/Productivity Loss In Patients With Rheumatological Conditions

Sarah Leggett1, Annelies Boonen2, Diane Lacaille3, Dorcas Beaton4, Bruno Fautrel5, Ailsa Bosworth6, Catherine Hoffstetter7, Sabrina Dadoun5, Carlo Alberto Scirè8, Sofia Hagel9, Mihai Bojinca10, Carina Mihai11, Antje Neuen12, Pam Rogers13, Denise Linton14, Ingemar Petersson15 and Suzanne Verstappen16, 1Arthritis Research UK Epidemiology Unit, Manchester Academic Health Science Centre,The University of Manchester, Manchester, United Kingdom, 2Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center, Maastricht, Netherlands, 3Rheumatology, Arthritis Research Centre of Canada, University of British Columbia, Richmond, BC, Canada, 4Scientist, Institute for Work & Health, Toronto, ON, Canada, 5APHP, Pitié-Salpêtrière University Hospital, Paris, France, 6National Rheumatoid Arthritis Society, Maidenhead, United Kingdom, 7Patient partner, Toronto, ON, Canada, 8Epidemiology Unit -Italian Society for Rheumatology, Milano, Italy, 9Department of Clinical Sciences Lund, Section for Rheumatology, Lund, Lund University and Skåne University Hospital, Lund, Sweden, 10Internal Medicine, “Dr. I. Cantacuzino” Hospital, Bucharest, Romania, 11Department of Internal Medicine and Rheumatology, Dr.I.Cantacuzino Hospital, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania, 12University Hospital Maastricht, Internal Medicine, Division of Rheumatology, Maastricht, Netherlands, 13Rheumatology, Arthritis Research Centre, Vancouver, BC, Canada, 14Mobility Clinical Research Unit, St. Michael's Hospital, Toronto, ON, Canada, 15Lund University, Department of Orthopedics, Clinical Sciences Lund, Lund, Sweden, 16Arthritis Research UK Epidemiology Unit, The University of Manchester, Manchester, United Kingdom

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: inflammatory arthritis, osteoarthritis and work

  • Tweet
  • Email
  • Print
Session Information

Title: Epidemiology and Health Services II & III

Session Type: Abstract Submissions (ACR)

Background/Purpose: There are a number of single item global measures available to explore at-work productivity loss (presenteeism) in patients with rheumatological conditions.  However, test-retest data are not available for all these measures and comparison data are lacking. The purposes of this study were i) to test-retest five at-work productivity loss global measures, including: Work Productivity Scale – Rheumatoid Arthritis (WPS-RA), Work Productivity and Activity Impairment Questionnaire (WPAI), Work Ability Index (WAI), Quality and Quantity questionnaire (QQ),and WHO Health and Performance Questionnaire (HPQ), ii) to explore the correlations between the 5 measures, and iii) to investigate the association between the 5 scales and disease activity.

Methods: In this international study 50 patients with a diagnosis of inflammatory arthritis or osteoarthritis in paid employment were recruited from 7 countries (United Kingdom, Sweden, France, The Netherlands, Romania, Italy, and Canada).  At baseline and 2 wk follow up, participants completed the five 10-point global measures (WPAI; 0=no effect on work – 10=completely prevented from working, WPS-RA; 0=no interference – 10=complete interference, WAI; 0=unable to work – 10=work ability at its best, QQ; 0= practically nothing/very poor quality – 10=normal quantity/very good quality, HPQ; 0=worst performance – 10=top performance).  VAS general well-being was also recorded at 2 wks.  Test-retest reliability was assessed applying intra-class correlation (ICC) statistics.  ICCs of 0.75 and 0.95 are generally regarded as good at respectively group and individual level.  Spearman correlations were calculated to determine the association between the two week global scores and between each scale with the VAS general well-being score.

Results:   54% of the study population was female; mean age was 44 (SD 10.2) yrs and median symptom duration 9.5 [IQR 5-15] yrs.  Median VAS general well-being was 28 [IQR 12-55].  72% of the study population had a non-manual occupation. ICC correlations were moderate at a group level: WPAI (r=0.65), WPS-RA (r=0.66), WAI (r=0.81), QQ-quantity (r=0.70), QQ-Quality (r=0.68) and HPQ (r=0.62).  The correlations between the 5 at-work productivity measures ranged from good (WPS-RA vs WPAI, r=0.92) to moderate (QQ-quality and QQ-quantity with all 4 other measures) (see table).  Correlations between each of the individual measures and VAS general well-being were low to moderate.

Conclusion: Overall, test-retest results of the 5 existing at-work productivity loss measures and the correlation between these 5 measures were moderate. The latter probably reflecting differences in concepts, recall periods, and references used in these measures.  The moderate association between the global at-work productivity measures and VAS general well-being suggests that the impact of arthritis on work is only partly captured by generic health measures.

 

Table. Spearman correlations between 5 at-work productivity loss measures and VAS general well-being

 

WPAI

WPS-RA

WAI

QQ – Quantity

QQ- Quality

HPQ- question C

VAS

well-being

WPAI

1

 

 

 

 

 

 

WPS-RA

0.92

1

 

 

 

 

 

WAI

-0.68

-0.70

1

 

 

 

 

QQ – quantity

-0.58

-0.59

0.57

1

 

 

 

QQ – quality

-0.58

-0.60

0.38

0.75

1

 

 

HPQ- question c

-0.71

-0.71

0.73

0.63

0.54

1

 

VAS well-being

0.56

0.66

-0.62

-0.37

-0.40

-0.60

1

 


Disclosure:

S. Leggett,
None;

A. Boonen,
None;

D. Lacaille,
None;

D. Beaton,
None;

B. Fautrel,
None;

A. Bosworth,
None;

C. Hoffstetter,
None;

S. Dadoun,
None;

C. A. Scirè,
None;

S. Hagel,
None;

M. Bojinca,
None;

C. Mihai,
None;

A. Neuen,
None;

P. Rogers,
None;

D. Linton,
None;

I. Petersson,
None;

S. Verstappen,
None.

  • Tweet
  • Email
  • Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/test-retest-reliability-of-five-global-measures-addressing-at-work-limitationsproductivity-loss-in-patients-with-rheumatological-conditions/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology